Clinical Management Guidelines for GATA2 Variants

This document provides an overview of clinical management guidelines for patients with pathogenic or likely pathogenic GATA2 variants. It emphasizes the importance of individualized treatment plans, genetic testing, and consultations with healthcare providers. Key recommendations include screening protocols, risk management, and referrals to specialists. The guidelines are based on the Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults, focusing on myelodysplastic syndr